nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproheptadine—DRD2—nicotine dependence	0.845	1	CbGaD
Cyproheptadine—Chest discomfort—Varenicline—nicotine dependence	0.00408	0.0658	CcSEcCtD
Cyproheptadine—Euphoric mood—Varenicline—nicotine dependence	0.0031	0.05	CcSEcCtD
Cyproheptadine—Increased appetite—Varenicline—nicotine dependence	0.00279	0.045	CcSEcCtD
Cyproheptadine—Irritability—Varenicline—nicotine dependence	0.0025	0.0404	CcSEcCtD
Cyproheptadine—Urinary retention—Varenicline—nicotine dependence	0.00249	0.0402	CcSEcCtD
Cyproheptadine—Pollakiuria—Varenicline—nicotine dependence	0.00209	0.0338	CcSEcCtD
Cyproheptadine—Photosensitivity reaction—Varenicline—nicotine dependence	0.00207	0.0334	CcSEcCtD
Cyproheptadine—Weight increased—Varenicline—nicotine dependence	0.00206	0.0333	CcSEcCtD
Cyproheptadine—Hallucination—Varenicline—nicotine dependence	0.00181	0.0291	CcSEcCtD
Cyproheptadine—Tinnitus—Varenicline—nicotine dependence	0.00169	0.0273	CcSEcCtD
Cyproheptadine—Chills—Varenicline—nicotine dependence	0.00163	0.0262	CcSEcCtD
Cyproheptadine—Vision blurred—Varenicline—nicotine dependence	0.00149	0.024	CcSEcCtD
Cyproheptadine—Tremor—Varenicline—nicotine dependence	0.00148	0.0239	CcSEcCtD
Cyproheptadine—Agitation—Varenicline—nicotine dependence	0.00145	0.0234	CcSEcCtD
Cyproheptadine—Vertigo—Varenicline—nicotine dependence	0.00142	0.0229	CcSEcCtD
Cyproheptadine—Syncope—Varenicline—nicotine dependence	0.00142	0.0228	CcSEcCtD
Cyproheptadine—Palpitations—Varenicline—nicotine dependence	0.0014	0.0225	CcSEcCtD
Cyproheptadine—Loss of consciousness—Varenicline—nicotine dependence	0.00139	0.0224	CcSEcCtD
Cyproheptadine—Convulsion—Varenicline—nicotine dependence	0.00137	0.0221	CcSEcCtD
Cyproheptadine—Oedema—Varenicline—nicotine dependence	0.00129	0.0208	CcSEcCtD
Cyproheptadine—Shock—Varenicline—nicotine dependence	0.00127	0.0204	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Varenicline—nicotine dependence	0.00126	0.0203	CcSEcCtD
Cyproheptadine—Tachycardia—Varenicline—nicotine dependence	0.00126	0.0203	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Varenicline—nicotine dependence	0.00125	0.0201	CcSEcCtD
Cyproheptadine—Anorexia—Varenicline—nicotine dependence	0.00123	0.0198	CcSEcCtD
Cyproheptadine—Hypotension—Varenicline—nicotine dependence	0.0012	0.0194	CcSEcCtD
Cyproheptadine—Insomnia—Varenicline—nicotine dependence	0.00117	0.0188	CcSEcCtD
Cyproheptadine—CHRM2—cardiovascular system—nicotine dependence	0.00115	0.0893	CbGeAlD
Cyproheptadine—Somnolence—Varenicline—nicotine dependence	0.00115	0.0185	CcSEcCtD
Cyproheptadine—Dyspepsia—Varenicline—nicotine dependence	0.00113	0.0183	CcSEcCtD
Cyproheptadine—Decreased appetite—Varenicline—nicotine dependence	0.00112	0.0181	CcSEcCtD
Cyproheptadine—Fatigue—Varenicline—nicotine dependence	0.00111	0.0179	CcSEcCtD
Cyproheptadine—Constipation—Varenicline—nicotine dependence	0.0011	0.0178	CcSEcCtD
Cyproheptadine—Feeling abnormal—Varenicline—nicotine dependence	0.00106	0.0171	CcSEcCtD
Cyproheptadine—CHRM1—cardiovascular system—nicotine dependence	0.00105	0.0813	CbGeAlD
Cyproheptadine—HTR2B—cardiovascular system—nicotine dependence	0.00104	0.0809	CbGeAlD
Cyproheptadine—Urticaria—Varenicline—nicotine dependence	0.00102	0.0165	CcSEcCtD
Cyproheptadine—HTR6—brain—nicotine dependence	0.000944	0.0731	CbGeAlD
Cyproheptadine—HTR1A—cardiovascular system—nicotine dependence	0.000935	0.0725	CbGeAlD
Cyproheptadine—Asthenia—Varenicline—nicotine dependence	0.000925	0.0149	CcSEcCtD
Cyproheptadine—Diarrhoea—Varenicline—nicotine dependence	0.000882	0.0142	CcSEcCtD
Cyproheptadine—HTR2C—midbrain—nicotine dependence	0.000868	0.0673	CbGeAlD
Cyproheptadine—Dizziness—Varenicline—nicotine dependence	0.000852	0.0137	CcSEcCtD
Cyproheptadine—Amitriptyline—OPRM1—nicotine dependence	0.000825	0.222	CrCbGaD
Cyproheptadine—Vomiting—Varenicline—nicotine dependence	0.00082	0.0132	CcSEcCtD
Cyproheptadine—Rash—Varenicline—nicotine dependence	0.000813	0.0131	CcSEcCtD
Cyproheptadine—Dermatitis—Varenicline—nicotine dependence	0.000812	0.0131	CcSEcCtD
Cyproheptadine—Headache—Varenicline—nicotine dependence	0.000808	0.013	CcSEcCtD
Cyproheptadine—Nausea—Varenicline—nicotine dependence	0.000766	0.0123	CcSEcCtD
Cyproheptadine—HRH1—Amine ligand-binding receptors—DRD2—nicotine dependence	0.000753	0.00986	CbGpPWpGaD
Cyproheptadine—CHRM1—Amine ligand-binding receptors—DRD2—nicotine dependence	0.000751	0.00983	CbGpPWpGaD
Cyproheptadine—CHRM3—Amine ligand-binding receptors—DRD2—nicotine dependence	0.000749	0.0098	CbGpPWpGaD
Cyproheptadine—CHRM2—Amine ligand-binding receptors—DRD2—nicotine dependence	0.000741	0.0097	CbGpPWpGaD
Cyproheptadine—HTR1A—midbrain—nicotine dependence	0.00073	0.0566	CbGeAlD
Cyproheptadine—Mianserin—DRD2—nicotine dependence	0.000729	0.196	CrCbGaD
Cyproheptadine—HTR1A—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.000709	0.00929	CbGpPWpGaD
Cyproheptadine—CHRM1—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.000689	0.00901	CbGpPWpGaD
Cyproheptadine—CHRM3—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.000687	0.00899	CbGpPWpGaD
Cyproheptadine—CHRM2—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.00068	0.0089	CbGpPWpGaD
Cyproheptadine—DRD2—midbrain—nicotine dependence	0.00066	0.0511	CbGeAlD
Cyproheptadine—Nortriptyline—DRD2—nicotine dependence	0.000651	0.175	CrCbGaD
Cyproheptadine—DRD2—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.000623	0.00815	CbGpPWpGaD
Cyproheptadine—HTR1A—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.000608	0.00796	CbGpPWpGaD
Cyproheptadine—CHRM2—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.000602	0.00788	CbGpPWpGaD
Cyproheptadine—HTR6—GPCR ligand binding—TAS2R16—nicotine dependence	0.00058	0.00759	CbGpPWpGaD
Cyproheptadine—Loxapine—DRD2—nicotine dependence	0.000579	0.156	CrCbGaD
Cyproheptadine—CHRM2—brain—nicotine dependence	0.000566	0.0438	CbGeAlD
Cyproheptadine—HTR2A—cardiovascular system—nicotine dependence	0.000557	0.0432	CbGeAlD
Cyproheptadine—HTR2C—brain—nicotine dependence	0.000545	0.0423	CbGeAlD
Cyproheptadine—HTR2B—GPCR ligand binding—TAS2R16—nicotine dependence	0.00053	0.00693	CbGpPWpGaD
Cyproheptadine—HTR2A—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.000526	0.00688	CbGpPWpGaD
Cyproheptadine—CHRM2—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.000516	0.00675	CbGpPWpGaD
Cyproheptadine—CHRM1—brain—nicotine dependence	0.000515	0.0399	CbGeAlD
Cyproheptadine—HTR2B—brain—nicotine dependence	0.000512	0.0397	CbGeAlD
Cyproheptadine—Clozapine—DRD2—nicotine dependence	0.000486	0.131	CrCbGaD
Cyproheptadine—CHRM3—brain—nicotine dependence	0.000461	0.0357	CbGeAlD
Cyproheptadine—HTR1A—brain—nicotine dependence	0.000459	0.0356	CbGeAlD
Cyproheptadine—SLC6A2—brain—nicotine dependence	0.000455	0.0353	CbGeAlD
Cyproheptadine—Amitriptyline—DRD2—nicotine dependence	0.000452	0.121	CrCbGaD
Cyproheptadine—HTR2A—midbrain—nicotine dependence	0.000435	0.0337	CbGeAlD
Cyproheptadine—HTR1A—GPCR ligand binding—TAS2R16—nicotine dependence	0.00043	0.00562	CbGpPWpGaD
Cyproheptadine—CHRM1—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.000429	0.00561	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCR ligand binding—TAS2R16—nicotine dependence	0.000427	0.00559	CbGpPWpGaD
Cyproheptadine—CHRM3—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.000427	0.00559	CbGpPWpGaD
Cyproheptadine—CHRM2—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.000423	0.00554	CbGpPWpGaD
Cyproheptadine—DRD2—brain—nicotine dependence	0.000415	0.0321	CbGeAlD
Cyproheptadine—CHRM1—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.000411	0.00538	CbGpPWpGaD
Cyproheptadine—CHRM3—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00041	0.00536	CbGpPWpGaD
Cyproheptadine—HTR1A—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.000406	0.00531	CbGpPWpGaD
Cyproheptadine—CHRM2—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.000406	0.00531	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR ligand binding—TAS2R16—nicotine dependence	0.000377	0.00494	CbGpPWpGaD
Cyproheptadine—HTR6—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000375	0.00491	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR ligand binding—TAS2R16—nicotine dependence	0.000371	0.00486	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR ligand binding—TAS2R16—nicotine dependence	0.00037	0.00485	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR ligand binding—TAS2R16—nicotine dependence	0.000369	0.00483	CbGpPWpGaD
Cyproheptadine—HTR1A—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.000369	0.00482	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR ligand binding—TAS2R16—nicotine dependence	0.000368	0.00482	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR ligand binding—TAS2R16—nicotine dependence	0.000364	0.00477	CbGpPWpGaD
Cyproheptadine—HTR2A—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.000351	0.00459	CbGpPWpGaD
Cyproheptadine—CHRM2—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.000344	0.00451	CbGpPWpGaD
Cyproheptadine—HTR2B—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000342	0.00448	CbGpPWpGaD
Cyproheptadine—HTR6—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000328	0.00429	CbGpPWpGaD
Cyproheptadine—HRH1—brain—nicotine dependence	0.000327	0.0254	CbGeAlD
Cyproheptadine—HTR6—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000321	0.0042	CbGpPWpGaD
Cyproheptadine—HTR2A—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.000318	0.00417	CbGpPWpGaD
Cyproheptadine—CHRM2—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.000313	0.00409	CbGpPWpGaD
Cyproheptadine—HTR2B—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000299	0.00392	CbGpPWpGaD
Cyproheptadine—HTR1A—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000299	0.00391	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling by GPCR—TAS2R16—nicotine dependence	0.000298	0.0039	CbGpPWpGaD
Cyproheptadine—HTR2B—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000293	0.00384	CbGpPWpGaD
Cyproheptadine—DRD2—Circadian rythm related genes—CHRNB2—nicotine dependence	0.000291	0.00381	CbGpPWpGaD
Cyproheptadine—CHRM1—Circadian rythm related genes—CHRNB2—nicotine dependence	0.000285	0.00373	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000278	0.00363	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000276	0.00361	CbGpPWpGaD
Cyproheptadine—HTR2A—brain—nicotine dependence	0.000274	0.0212	CbGeAlD
Cyproheptadine—HTR2B—Signaling by GPCR—TAS2R16—nicotine dependence	0.000272	0.00356	CbGpPWpGaD
Cyproheptadine—HTR6—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000271	0.00355	CbGpPWpGaD
Cyproheptadine—SLC6A2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000264	0.00346	CbGpPWpGaD
Cyproheptadine—DRD2—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000263	0.00344	CbGpPWpGaD
Cyproheptadine—HTR6—GPCR downstream signaling—FGD1—nicotine dependence	0.000257	0.00337	CbGpPWpGaD
Cyproheptadine—CHRM2—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000254	0.00332	CbGpPWpGaD
Cyproheptadine—HTR2B—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000247	0.00324	CbGpPWpGaD
Cyproheptadine—HTR6—GPCR ligand binding—OPRM1—nicotine dependence	0.000245	0.0032	CbGpPWpGaD
Cyproheptadine—DRD2—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000244	0.00319	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000243	0.00318	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000242	0.00316	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00024	0.00314	CbGpPWpGaD
Cyproheptadine—HRH1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000239	0.00313	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000238	0.00312	CbGpPWpGaD
Cyproheptadine—HTR1A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000238	0.00311	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000238	0.00311	CbGpPWpGaD
Cyproheptadine—HTR2C—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000237	0.0031	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000235	0.00308	CbGpPWpGaD
Cyproheptadine—HTR2B—GPCR downstream signaling—FGD1—nicotine dependence	0.000235	0.00307	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling by GPCR—FGD1—nicotine dependence	0.000234	0.00306	CbGpPWpGaD
Cyproheptadine—HTR6—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000232	0.00304	CbGpPWpGaD
Cyproheptadine—HTR2B—GPCR ligand binding—OPRM1—nicotine dependence	0.000223	0.00292	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—TAS2R16—nicotine dependence	0.00022	0.00289	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—TAS2R16—nicotine dependence	0.000219	0.00287	CbGpPWpGaD
Cyproheptadine—HTR1A—G alpha (i) signalling events—DRD2—nicotine dependence	0.000216	0.00283	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—FGD1—nicotine dependence	0.000213	0.00279	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000213	0.00279	CbGpPWpGaD
Cyproheptadine—HTR2B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000212	0.00277	CbGpPWpGaD
Cyproheptadine—CHRM1—Circadian rythm related genes—DRD2—nicotine dependence	0.000211	0.00276	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00021	0.00274	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000209	0.00274	CbGpPWpGaD
Cyproheptadine—DRD2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000209	0.00273	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000209	0.00273	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000208	0.00272	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000206	0.00269	CbGpPWpGaD
Cyproheptadine—HTR2A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000205	0.00269	CbGpPWpGaD
Cyproheptadine—HRH1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000205	0.00268	CbGpPWpGaD
Cyproheptadine—CHRM1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000204	0.00267	CbGpPWpGaD
Cyproheptadine—CHRM3—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000204	0.00267	CbGpPWpGaD
Cyproheptadine—CHRM2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000202	0.00264	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000201	0.00263	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.0002	0.00261	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—TAS2R16—nicotine dependence	0.000194	0.00253	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCR downstream signaling—FGD1—nicotine dependence	0.00019	0.00249	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—TAS2R16—nicotine dependence	0.00019	0.00249	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—TAS2R16—nicotine dependence	0.00019	0.00249	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCR downstream signaling—FGD1—nicotine dependence	0.00019	0.00248	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—TAS2R16—nicotine dependence	0.000189	0.00248	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—TAS2R16—nicotine dependence	0.000189	0.00247	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—TAS2R16—nicotine dependence	0.000187	0.00245	CbGpPWpGaD
Cyproheptadine—CHRM2—G alpha (i) signalling events—DRD2—nicotine dependence	0.000183	0.0024	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCR ligand binding—OPRM1—nicotine dependence	0.000181	0.00237	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCR ligand binding—OPRM1—nicotine dependence	0.00018	0.00236	CbGpPWpGaD
Cyproheptadine—HTR6—GPCR ligand binding—DRD2—nicotine dependence	0.000177	0.00231	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—TAS2R16—nicotine dependence	0.000176	0.0023	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000173	0.00227	CbGpPWpGaD
Cyproheptadine—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000173	0.00226	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—FGD1—nicotine dependence	0.000173	0.00226	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000172	0.00226	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—FGD1—nicotine dependence	0.000172	0.00225	CbGpPWpGaD
Cyproheptadine—UGT1A3—Metabolism—CYP2A7—nicotine dependence	0.000172	0.00225	CbGpPWpGaD
Cyproheptadine—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000172	0.00225	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000172	0.00225	CbGpPWpGaD
Cyproheptadine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000171	0.00224	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00017	0.00223	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR downstream signaling—FGD1—nicotine dependence	0.000167	0.00219	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR downstream signaling—FGD1—nicotine dependence	0.000165	0.00215	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR downstream signaling—FGD1—nicotine dependence	0.000164	0.00215	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR downstream signaling—FGD1—nicotine dependence	0.000164	0.00214	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR downstream signaling—FGD1—nicotine dependence	0.000163	0.00214	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR downstream signaling—FGD1—nicotine dependence	0.000162	0.00211	CbGpPWpGaD
Cyproheptadine—HTR2B—GPCR ligand binding—DRD2—nicotine dependence	0.000161	0.00211	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—TAS2R16—nicotine dependence	0.000161	0.0021	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR ligand binding—OPRM1—nicotine dependence	0.000159	0.00208	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR ligand binding—OPRM1—nicotine dependence	0.000156	0.00205	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR ligand binding—OPRM1—nicotine dependence	0.000156	0.00204	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR ligand binding—OPRM1—nicotine dependence	0.000156	0.00204	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR ligand binding—OPRM1—nicotine dependence	0.000155	0.00203	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR ligand binding—OPRM1—nicotine dependence	0.000154	0.00201	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—FGD1—nicotine dependence	0.000152	0.00199	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—FGD1—nicotine dependence	0.000149	0.00196	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—FGD1—nicotine dependence	0.000149	0.00195	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—FGD1—nicotine dependence	0.000149	0.00195	CbGpPWpGaD
Cyproheptadine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000149	0.00194	CbGpPWpGaD
Cyproheptadine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000148	0.00194	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—FGD1—nicotine dependence	0.000148	0.00194	CbGpPWpGaD
Cyproheptadine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000148	0.00193	CbGpPWpGaD
Cyproheptadine—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000147	0.00193	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—FGD1—nicotine dependence	0.000147	0.00192	CbGpPWpGaD
Cyproheptadine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000146	0.00191	CbGpPWpGaD
Cyproheptadine—HTR6—GPCR downstream signaling—OPRM1—nicotine dependence	0.000138	0.00181	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—FGD1—nicotine dependence	0.000138	0.00181	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCR ligand binding—DRD2—nicotine dependence	0.000131	0.00171	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCR ligand binding—DRD2—nicotine dependence	0.00013	0.0017	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—TAS2R16—nicotine dependence	0.00013	0.0017	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—TAS2R16—nicotine dependence	0.00013	0.0017	CbGpPWpGaD
Cyproheptadine—HTR2B—GPCR downstream signaling—OPRM1—nicotine dependence	0.000126	0.00165	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—FGD1—nicotine dependence	0.000126	0.00165	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling by GPCR—OPRM1—nicotine dependence	0.000126	0.00164	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—AKR1B10—nicotine dependence	0.000122	0.0016	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—OPRM1—nicotine dependence	0.000115	0.0015	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—TAS2R16—nicotine dependence	0.000114	0.0015	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR ligand binding—DRD2—nicotine dependence	0.000113	0.00148	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR ligand binding—DRD2—nicotine dependence	0.000113	0.00148	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—TAS2R16—nicotine dependence	0.000113	0.00147	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR ligand binding—DRD2—nicotine dependence	0.000112	0.00147	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—TAS2R16—nicotine dependence	0.000112	0.00147	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR ligand binding—DRD2—nicotine dependence	0.000112	0.00147	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—TAS2R16—nicotine dependence	0.000112	0.00146	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—TAS2R16—nicotine dependence	0.000112	0.00146	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—AKR1B10—nicotine dependence	0.000111	0.00146	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR ligand binding—DRD2—nicotine dependence	0.000111	0.00145	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—TAS2R16—nicotine dependence	0.00011	0.00145	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCR downstream signaling—OPRM1—nicotine dependence	0.000102	0.00134	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—FGD1—nicotine dependence	0.000102	0.00134	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCR downstream signaling—OPRM1—nicotine dependence	0.000102	0.00133	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—FGD1—nicotine dependence	0.000102	0.00133	CbGpPWpGaD
Cyproheptadine—HTR6—GPCR downstream signaling—DRD2—nicotine dependence	9.99e-05	0.00131	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—OPRM1—nicotine dependence	9.29e-05	0.00122	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—OPRM1—nicotine dependence	9.25e-05	0.00121	CbGpPWpGaD
Cyproheptadine—HTR2B—GPCR downstream signaling—DRD2—nicotine dependence	9.12e-05	0.00119	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling by GPCR—DRD2—nicotine dependence	9.08e-05	0.00119	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—AKR1B10—nicotine dependence	9.03e-05	0.00118	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR downstream signaling—OPRM1—nicotine dependence	8.98e-05	0.00118	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—AKR1B10—nicotine dependence	8.98e-05	0.00118	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—FGD1—nicotine dependence	8.97e-05	0.00117	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR downstream signaling—OPRM1—nicotine dependence	8.84e-05	0.00116	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—FGD1—nicotine dependence	8.83e-05	0.00116	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR downstream signaling—OPRM1—nicotine dependence	8.82e-05	0.00115	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—FGD1—nicotine dependence	8.81e-05	0.00115	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR downstream signaling—OPRM1—nicotine dependence	8.79e-05	0.00115	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—FGD1—nicotine dependence	8.78e-05	0.00115	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR downstream signaling—OPRM1—nicotine dependence	8.77e-05	0.00115	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—FGD1—nicotine dependence	8.75e-05	0.00115	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR downstream signaling—OPRM1—nicotine dependence	8.68e-05	0.00114	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—FGD1—nicotine dependence	8.67e-05	0.00113	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—CYP2A7—nicotine dependence	8.6e-05	0.00113	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—WASF2—nicotine dependence	8.59e-05	0.00112	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—DRD2—nicotine dependence	8.28e-05	0.00108	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—WASF1—nicotine dependence	8.24e-05	0.00108	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—OPRM1—nicotine dependence	8.16e-05	0.00107	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—OPRM1—nicotine dependence	8.03e-05	0.00105	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—OPRM1—nicotine dependence	8.01e-05	0.00105	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—OPRM1—nicotine dependence	7.99e-05	0.00105	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—OPRM1—nicotine dependence	7.96e-05	0.00104	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—AKR1B10—nicotine dependence	7.93e-05	0.00104	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—OPRM1—nicotine dependence	7.88e-05	0.00103	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—WASF2—nicotine dependence	7.84e-05	0.00103	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—AKR1B10—nicotine dependence	7.8e-05	0.00102	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—AKR1B10—nicotine dependence	7.78e-05	0.00102	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—AKR1B10—nicotine dependence	7.76e-05	0.00102	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—AKR1B10—nicotine dependence	7.73e-05	0.00101	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—AKR1B10—nicotine dependence	7.66e-05	0.001	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—WASF1—nicotine dependence	7.52e-05	0.000984	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—OPRM1—nicotine dependence	7.42e-05	0.000971	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCR downstream signaling—DRD2—nicotine dependence	7.4e-05	0.000968	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCR downstream signaling—DRD2—nicotine dependence	7.36e-05	0.000963	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—OPRM1—nicotine dependence	6.77e-05	0.000886	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—DRD2—nicotine dependence	6.72e-05	0.000879	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—DRD2—nicotine dependence	6.68e-05	0.000875	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR downstream signaling—DRD2—nicotine dependence	6.39e-05	0.000837	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR downstream signaling—DRD2—nicotine dependence	6.38e-05	0.000835	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—WASF2—nicotine dependence	6.36e-05	0.000832	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR downstream signaling—DRD2—nicotine dependence	6.36e-05	0.000832	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR downstream signaling—DRD2—nicotine dependence	6.34e-05	0.000829	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—WASF2—nicotine dependence	6.33e-05	0.000828	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR downstream signaling—DRD2—nicotine dependence	6.28e-05	0.000821	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—WASF1—nicotine dependence	6.1e-05	0.000798	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—WASF1—nicotine dependence	6.07e-05	0.000794	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—DRD2—nicotine dependence	5.8e-05	0.00076	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—DRD2—nicotine dependence	5.79e-05	0.000758	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—DRD2—nicotine dependence	5.77e-05	0.000756	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—DRD2—nicotine dependence	5.75e-05	0.000753	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—DRD2—nicotine dependence	5.7e-05	0.000746	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—WASF2—nicotine dependence	5.58e-05	0.000731	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—WASF2—nicotine dependence	5.49e-05	0.000719	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—OPRM1—nicotine dependence	5.49e-05	0.000718	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—WASF2—nicotine dependence	5.48e-05	0.000718	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—WASF2—nicotine dependence	5.46e-05	0.000715	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—OPRM1—nicotine dependence	5.46e-05	0.000715	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—WASF2—nicotine dependence	5.45e-05	0.000713	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—WASF2—nicotine dependence	5.39e-05	0.000706	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—DRD2—nicotine dependence	5.36e-05	0.000702	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—WASF1—nicotine dependence	5.35e-05	0.000701	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—WASF1—nicotine dependence	5.27e-05	0.000689	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—WASF1—nicotine dependence	5.26e-05	0.000688	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—WASF1—nicotine dependence	5.24e-05	0.000686	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—WASF1—nicotine dependence	5.22e-05	0.000684	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—WASF1—nicotine dependence	5.17e-05	0.000677	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—DRD2—nicotine dependence	4.89e-05	0.000641	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—OPRM1—nicotine dependence	4.82e-05	0.000631	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—OPRM1—nicotine dependence	4.74e-05	0.000621	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—OPRM1—nicotine dependence	4.73e-05	0.000619	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—OPRM1—nicotine dependence	4.72e-05	0.000617	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—OPRM1—nicotine dependence	4.7e-05	0.000615	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—OPRM1—nicotine dependence	4.66e-05	0.000609	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—DRD2—nicotine dependence	3.97e-05	0.000519	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—DRD2—nicotine dependence	3.95e-05	0.000517	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—DRD2—nicotine dependence	3.43e-05	0.000449	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—DRD2—nicotine dependence	3.42e-05	0.000448	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—DRD2—nicotine dependence	3.41e-05	0.000446	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—DRD2—nicotine dependence	3.4e-05	0.000445	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—DRD2—nicotine dependence	3.37e-05	0.000441	CbGpPWpGaD
